Oncotarget
The cover for issue 26 of Oncotarget features Figure 2, "LuCSC-holoclones initiate rim-like niches and their differentiation creates pseudo-alveoli structures," by Xiao, et al.
Rapid transitions in the standard of care for chronic lymphocytic leukemia (CLL) |
https://doi.org/10.18632/oncotarget.26826 Erlene K. Seymour |
2484-2485 |
PDF | How to cite | Order a Reprint |
The triacylglycerol, hydroxytriolein, inhibits triple negative mammary breast cancer cell proliferation through a mechanism dependent on dihydroceramide and Akt |
https://doi.org/10.18632/oncotarget.26824 Francisca Guardiola-Serrano, Roberto Beteta-Göbel, Raquel Rodríguez-Lorca, Maitane Ibarguren, David J. López, Silvia Terés, María Alonso-Sande, Mónica Higuera, Manuel Torres, Xavier Busquets, and Pablo V. Escribá |
2486-2507 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Comparative proteomic analysis of human serum before and after liver transplantation using quantitative proteomics |
https://doi.org/10.18632/oncotarget.26761 Ruohan Zhang, Minglin Ou, Yue Zhang, Qiang Yan, Huaizhou Chen, Liusheng Lai, Ying Li, Feilong Xu, Donge Tang, Xuyong Sun, Jianhui Dong, Yong Dai, and Weiguo Sui |
2508-2514 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Large-scale in-silico identification of a tumor-specific antigen pool for targeted immunotherapy in triple-negative breast cancer |
https://doi.org/10.18632/oncotarget.26808 Jessica Kaufmann, Nicolas Wentzensen, Titus J. Brinker, and Niels Grabe |
2515-2529 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD+ acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.26811 Yoko Ueno, Masamichi Mori, Yoshiteru Kamiyama, Rika Saito, Naoki Kaneko, Eriko Isshiki, Sadao Kuromitsu, and Masahiro Takeuchi |
2530-2545 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach |
https://doi.org/10.18632/oncotarget.26817 Zhiguang Xiao, Bianca Sperl, Silvia Gärtner, Tatiana Nedelko, Elvira Stacher-Priehse, Axel Ullrich, and Pjotr G. Knyazev |
2546-2560 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Role of surgery in gynaecological sarcomas |
https://doi.org/10.18632/oncotarget.26803 Valentina Ghirardi, Nicolò Bizzarri, Francesco Guida, Carmine Vascone, Barbara Costantini, Giovanni Scambia, and Anna Fagotti |
2561-2575 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer |
https://doi.org/10.18632/oncotarget.26855 Teresa Morán, Eudald Felip, Joaquim Bosch-Barrera, Itziar de Aguirre, Jose Luis Ramirez, Carles Mesia, Enric Carcereny, Diana Roa, Elia Sais, Yolanda García, Remei Blanco, Silvia Sanchez, Claudia Rosa Villacorta, Cristina Queralt, Jose María Velarde, and Rafael Rosell |
2576-2576 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC